BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34198586)

  • 1. The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases.
    Jarrar Y; Lee SJ
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34198586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
    Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
    Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts.
    Vienneau DS; DeBoni U; Wells PG
    Cancer Res; 1995 Mar; 55(5):1045-51. PubMed ID: 7866987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of functional UDP-glucuronosyltransferases 1A and 2B in common marmosets.
    Uno Y; Uehara S; Inoue T; Kawamura S; Murayama N; Nishikawa M; Ikushiro S; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2020 Feb; 172():113748. PubMed ID: 31830470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.
    Guillemette C
    Pharmacogenomics J; 2003; 3(3):136-58. PubMed ID: 12815363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.
    Strassburg CP; Kneip S; Topp J; Obermayer-Straub P; Barut A; Tukey RH; Manns MP
    J Biol Chem; 2000 Nov; 275(46):36164-71. PubMed ID: 10748067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.
    Rowland A; Miners JO; Mackenzie PI
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1121-32. PubMed ID: 23500526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.
    Fujiwara R; Yokoi T; Nakajima M
    Front Pharmacol; 2016; 7():388. PubMed ID: 27822186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-, sex- and development-specific transcription profiles of eight UDP-glucuronosyltransferase genes in zebrafish (Danio rerio) and their regulation by activator of aryl hydrocarbon receptor.
    Christen V; Fent K
    Aquat Toxicol; 2014 May; 150():93-102. PubMed ID: 24667232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of human UDP-glucuronosyltransferase genes.
    Hu DG; Meech R; McKinnon RA; Mackenzie PI
    Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
    Yang N; Sun R; Liao X; Aa J; Wang G
    Pharmacol Res; 2017 Jul; 121():169-183. PubMed ID: 28479371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation in humans. Pharmacogenetic and developmental aspects.
    de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
    Clin Pharmacokinet; 1999 Jun; 36(6):439-52. PubMed ID: 10427468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Protein Interactome of Human UDP-Glucuronosyltransferases Exposed by Untargeted Proteomics.
    Rouleau M; Audet-Delage Y; Desjardins S; Rouleau M; Girard-Bock C; Guillemette C
    Front Pharmacol; 2017; 8():23. PubMed ID: 28217095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A).
    Osborne MJ; Coutinho de Oliveira L; Volpon L; Borden KLB
    Biomol NMR Assign; 2018 Oct; 12(2):315-318. PubMed ID: 29934866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques.
    Uno Y; Takahira R; Murayama N; Ishii Y; Ikenaka Y; Ishizuka M; Yamazaki H; Ikushiro S
    Biochem Pharmacol; 2018 Sep; 155():172-181. PubMed ID: 29944869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
    Lu L; Zhou J; Shi J; Peng XJ; Qi XX; Wang Y; Li FY; Zhou FY; Liu L; Liu ZQ
    PLoS One; 2015; 10(5):e0127524. PubMed ID: 26010150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.
    Mackenzie PI; Miners JO; McKinnon RA
    Clin Chem Lab Med; 2000 Sep; 38(9):889-92. PubMed ID: 11097345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol.
    Dong RH; Fang ZZ; Zhu LL; Liang SC; Ge GB; Yang L; Liu ZY
    Phytother Res; 2012 Jan; 26(1):86-90. PubMed ID: 21544887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation.
    Burchell B
    Am J Pharmacogenomics; 2003; 3(1):37-52. PubMed ID: 12562215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.
    Kutsuno Y; Sumida K; Itoh T; Tukey RH; Fujiwara R
    Pharmacol Res Perspect; 2013 Oct; 1(1):e00002. PubMed ID: 25505556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.